Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa2g04322 | ATGTTTACCACCAAACTCCTCTCTCTTCTTCTTCTCTTGTCATTCTTCTCACTCTCCACACATGCCGCCAATTCAAGCGAACTCGAAATTCTCCTAAACATAAAATCCTCATTTTCAAACTCCAACTCCAAACCCTTGTTCAACTCATGGAATCCCAACAATTCCATTTGCAGTTTCTATGGAATCACCTGCAACTCAGTCAACTCCGTCGCAGAAATAAACCTCTCCCACAGAAACCTCACCGGAACTCTCCCTCTACACTCCCTCTGCAACCTTCCCTCCCTCACCAAACTCGTCTTCAGCTTCAACCTTCTTCATGGCAGACTCAATCAAACCCTTCTAAACTGCGTCAAACTAGAGTTCTTAGATTTAGGAAACAACTTCTTCAACGGAGCTTTCCCAGATATTTCACCTCTCAATAAACTTCAATATCTTTACGTTAACAAAAGTGGTTTCTCTGGAACTTTTCCTTGGCAATCTCTGTTAAACATGACGGGTCTGTTACAGTTAAGCGTGGGAGATAACGCGTTCGATCTAACGCCGTTTCCTAAAGAAGTCTTAACTCTCAAGAAACTTAACTGGCTTTACATGAGTAACTGTAACATAGGAGGAAATTTACCGGTTGGAATCGGTAACTTGACGGAGTTAACCGAGTTAGAATTCTCTGATAATTTCATCACGGGGGAGCTTCCTGGAGATATAGTCAATCTTCGAAAACTCTGGCAGCTTGAATTCTACAATAATTCATTATCCGGAGAGCTTCCGGTCGGGTTGAGAAACTTAACCCAACTCATAAACTTCGATGGATCAATGAATCAGTTAGAAGGAAATCTCTCCGAGATAAGATTCTTAACTAATCTTGTTTCACTTCAATTCTTTGAAAACAAATTCTCCGGCGAGATTCCGGCAGAGTTAGGCGAGTTCAAACGTCTTAACGCTCTGTCACTTTATAGAAACAGATTAACAGGTCCGATTCCTCAGAATATCGGTTCGTGGACAAAGTTTAGATACATAGACGTTTCGGAGAATTTCTTGACAGGTTCTATTCCTCCGGATATGTGTAGCAAAGGAAACATGACAGAGCTTCTTTTGCTTCAGAATAATCTCACCGGAGAGATACCGCAAACATACGGTAACTGTTTAACTTTGAAACGATTCAGAGTGAGTCGAAACTCTCTTTCTGGTATTGTTCCTTCGAGTATCTGGGGATTACCTAAAGTTGAAATTATTGATATTGAAATGAATCAGTTAGAAGGTTCTGTAAGTTCTGATATCCAGAATGCAAAAAAATTGACAAGTATTTTCGCAAGGAGTAATCGGTTATCCGGTGAAATACCGGAAGAGATTGTGAAAGCGACTTCGTTGGTGACAATTGATCTTAGCGAGAATCAAATTTCAAGGAACATTCCAGAAGGAATTGGTGAGCTTAAGCAGCTTGGGAACCTTCATCTGCAAGGTAACAAGTTATCCGGGATAATTCCAGAATCTTTGGGTAGTTGTAACTCTTTAAATGATGTTGATCTATCGCGAAATTTACTTTCGGACGAAATTCCTTCGTCGTTGGGTCTGTTACCGGCTTTGAATTCATTGAATTTCTCTAGCAATGAACTTTCCGGTGAGATACCGGAGAGGTTAGGTTCGCTTAAGTTGAGTCTCTTTGATCTTTCGCATAATAGATTATCCGGTGAAATTCCACAGGGTTTGACAATTCAGGCCTACAATGGAAGTCTCGCCGGAAACCCGGGTTTATGCACTCTCGATGGTATTGGTTCCTTCCGGCGTTGCTCAGAGAGTGGTGGAATATCGAAAGACGTTCGTGCTCTTGTACTTTGTTTTACAATAGGTTTGGTTTTGGTTCTTTCTTTTGTGGGTGTTTATCTGAAATTGAGGAGAATGAAGGAAAAAGAGATGAAAGGAGAGGGAAGAAAATATGGAAGGGAACGTTCTTTGAAGGAAGAATCGTGGGATGTGAAATCCTTCCATGTGATGAGTTTCAGTGAAGATGAGATTCTTGATTCTATAAAGCAAGAGAATCTAATAGGAAAAGGAGGTTCAGGGAATGTTTATAGAGTCACACTCGCAAATGGAAAAGAACTCGCGGTTAAGCATATATGGAACACTGATTTCAGTTCTAGGAAAAAGTCATGGAGTAGTACTCCGATGCTGGCGAAGCGCGGAGGTGGTGGAGGTTCAAAGTCGAGGGAGTTCGACGCAGAGGTTCAGTCGTTGAGTTCGATAAGGCACGTCAATGTGGTGAAACTTTACTGCAGTATAACGAGCGAGGACTCGAGTTTATTGGTGTACGAGTATTTGCCGAATGGGAGTTTGTGGGATAGGCTTCATACTAATGAGAAGATGGAGCTTGATTGGGAAACAAGATATGAAATTGCTATTGGTGCTGCTAAAGGGTTGGAGTATTTGCATCATGGGTGTGAAAGGCCTGTGATTCATAGAGATGTTAAGTCTAGTAACATTTTGTTGGATGAGTTTTTGAAACCTAGGATTGCTGATTTTGGTCTTGCTAAGATTGTTCATGCCAATGTTGTTAAGGATTCTACTCATATCATCGCCGGAACTCACGGCTACATCGCTCCCGAATATGGTTACACATACAGAGTGAATGAGAAAAGTGATGTGTATAGTTTCGGAGTCGTGTTGATGGAGCTAGTAACTGGTAAAAGGCCAAGTGAGACAGAGTTCGGAGAAAACAAGGATATAGTTAGTTGGGTTCATGGGAAGACAAGGAGTAAGGAAAAGTTTATGAGTGTGGTGGATTCGAGAATTCCGGAGATGTATAAAGAGGAAGCTTGTAAGGTTTTGAGAACTGCAGTTCTTTGCACTGCAACTCTTCCTGCTTTGAGACCAAGTATGAGAAGTGTGGTTCAACAGCTTGAGGATGCTGCACCTTGTAAATTGGTTGGAATTGTTATTGGCAAACATGGAAGTGAAAAGAAATTTGGAGTCAATGACAAATGA | 2976 | 0.413 | MFTTKLLSLLLLLSFFSLSTHAANSSELEILLNIKSSFSNSNSKPLFNSWNPNNSICSFYGITCNSVNSVAEINLSHRNLTGTLPLHSLCNLPSLTKLVFSFNLLHGRLNQTLLNCVKLEFLDLGNNFFNGAFPDISPLNKLQYLYVNKSGFSGTFPWQSLLNMTGLLQLSVGDNAFDLTPFPKEVLTLKKLNWLYMSNCNIGGNLPVGIGNLTELTELEFSDNFITGELPGDIVNLRKLWQLEFYNNSLSGELPVGLRNLTQLINFDGSMNQLEGNLSEIRFLTNLVSLQFFENKFSGEIPAELGEFKRLNALSLYRNRLTGPIPQNIGSWTKFRYIDVSENFLTGSIPPDMCSKGNMTELLLLQNNLTGEIPQTYGNCLTLKRFRVSRNSLSGIVPSSIWGLPKVEIIDIEMNQLEGSVSSDIQNAKKLTSIFARSNRLSGEIPEEIVKATSLVTIDLSENQISRNIPEGIGELKQLGNLHLQGNKLSGIIPESLGSCNSLNDVDLSRNLLSDEIPSSLGLLPALNSLNFSSNELSGEIPERLGSLKLSLFDLSHNRLSGEIPQGLTIQAYNGSLAGNPGLCTLDGIGSFRRCSESGGISKDVRALVLCFTIGLVLVLSFVGVYLKLRRMKEKEMKGEGRKYGRERSLKEESWDVKSFHVMSFSEDEILDSIKQENLIGKGGSGNVYRVTLANGKELAVKHIWNTDFSSRKKSWSSTPMLAKRGGGGGSKSREFDAEVQSLSSIRHVNVVKLYCSITSEDSSLLVYEYLPNGSLWDRLHTNEKMELDWETRYEIAIGAAKGLEYLHHGCERPVIHRDVKSSNILLDEFLKPRIADFGLAKIVHANVVKDSTHIIAGTHGYIAPEYGYTYRVNEKSDVYSFGVVLMELVTGKRPSETEFGENKDIVSWVHGKTRSKEKFMSVVDSRIPEMYKEEACKVLRTAVLCTATLPALRPSMRSVVQQLEDAAPCKLVGIVIGKHGSEKKFGVNDK | 991 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa2g04322 | 991 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 | 771 | 977 | - | - | |
Vifa2g04322 | 991 | Gene3D | Ribonuclease Inhibitor | 283 | 352 | IPR032675 | - | |
Vifa2g04322 | 991 | SMART | serkin_6 | 674 | 971 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g04322 | 991 | Gene3D | Transferase(Phosphotransferase) domain 1 | 771 | 971 | - | - | |
Vifa2g04322 | 991 | Gene3D | Ribonuclease Inhibitor | 180 | 282 | IPR032675 | - | |
Vifa2g04322 | 991 | Gene3D | Ribonuclease Inhibitor | 24 | 179 | IPR032675 | - | |
Vifa2g04322 | 991 | ProSitePatterns | Protein kinases ATP-binding region signature. | 680 | 702 | IPR017441 | GO:0005524 | |
Vifa2g04322 | 991 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 470 | 590 | - | - | |
Vifa2g04322 | 991 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 210 | 965 | - | - | |
Vifa2g04322 | 991 | Pfam | Protein kinase domain | 676 | 962 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g04322 | 991 | Gene3D | Ribonuclease Inhibitor | 353 | 599 | IPR032675 | - | |
Vifa2g04322 | 991 | ProSiteProfiles | Protein kinase domain profile. | 674 | 968 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g04322 | 991 | Pfam | Leucine rich repeat N-terminal domain | 25 | 65 | IPR013210 | - | |
Vifa2g04322 | 991 | SUPERFAMILY | RNI-like | 280 | 587 | - | - | |
Vifa2g04322 | 991 | FunFam | Receptor-like protein kinase 7 | 109 | 355 | - | - | |
Vifa2g04322 | 991 | CDD | STKc_IRAK | 680 | 965 | - | - | |
Vifa2g04322 | 991 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 356 | 445 | - | - | |
Vifa2g04322 | 991 | Gene3D | Phosphorylase Kinase; domain 1 | 657 | 770 | - | - | |
Vifa2g04322 | 991 | SUPERFAMILY | Protein kinase-like (PK-like) | 665 | 964 | IPR011009 | - | |
Vifa2g04322 | 991 | SUPERFAMILY | L domain-like | 49 | 326 | - | - | |
Vifa2g04322 | 991 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 815 | 827 | IPR008271 | GO:0004672|GO:0006468 | |
Vifa2g04322 | 991 | FunFam | Receptor-like protein kinase HAIKU2 | 657 | 770 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa2g04322 | Vifa-Chr2 | 1273068738 | 1273071793 | Dispersed/Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa2g04322 | 7 | 984 | Receptor kinase-like Gene Family | AT1G09970 | 59.003 | 0.0 | 1120 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Vifa2g04322 | Pkinase | 5.1e-42 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa2g04322 | - | - | gmx:100809356 | 1490.32 |